A/Prof Matthew Foote

Associate Professor Matthew Foote is a highly accomplished radiation oncologist specialising in brain and spinal (CNS) cancer, head and neck cancer, skin cancer, and stereotactic radiation therapy. He practices primarily in Cleveland, Brisbane, in the state of Queensland, Australia. Currently associated with Greenslopes Private Hospital, A/Prof Foote has established himself as a prominent figure in the field of oncology.

A/Prof Foote completed his specialist training in Brisbane in 2009 and subsequently pursued further sub-specialist training in Gamma Knife® radiosurgery, stereotactic radiotherapy, and neuro-oncology at the renowned Princess Margaret Hospital in Toronto. With his extensive experience in stereotactic brain and body radiotherapy, neuro-oncology, head and neck cancer, and cutaneous (skin) cancer, A/Prof Foote has been instrumental in providing advanced and cutting-edge treatment options to his patients.

Since 2010, A/Prof Foote has been actively involved in international, national, and local clinical trials in melanoma, non-melanoma skin cancer, and neuro-oncology. As the Principal Investigator of these trials, he is responsible for their design, planning, and execution. He also serves on the management and scientific committees of the Co-operative Trials Group for Neuro-oncology (COGNO). A/Prof Foote's work in stereotactic body and brain radiotherapy has gained international recognition, and he is committed to establishing new stereotactic programs throughout Australia and South East Asia.

Apart from his clinical practice, A/Prof Foote is dedicated to medical education and actively participates in medical research in melanoma and skin cancer. He collaborates with researchers at the Translational Research Institute, contributing to the advancement of knowledge and treatment options in these fields. A/Prof Foote holds professional memberships with prestigious organizations such as the International Stereotactic Radiosurgery Society (ISRS), Co-operative Trials Group for Neuro-oncology (COGNO), Australia and New Zealand Melanoma Trials Group (ANZMTG), the Australia and New Zealand Head and Neck Cancer Society (ANZHNS), and the Trans-Tasman Radiation Oncology Group (TROG).

With his expertise, passion for his work, and ongoing commitment to medical research and education, A/Prof Foote continues to make significant contributions to the field of cancer treatment and research. His dedication to improving patient outcomes and his involvement in clinical trials and advancements in stereotactic radiotherapy have positioned him as a respected and sought-after radiation oncologist in Australia and beyond.